17419-41-9

Basic information

• Product Name: 2,4-dichloro-6-cyclohexyl-[1,3,5]triazine
• Synonyms: 2,4-dichloro-6-cyclohexyl-[1,3,5]triazine
• CAS NO: 17419-41-9
• Molecular Weight: 232.112
• Mol File: 17419-41-9.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 2,4-dichloro-6-cyclohexyl-[1,3,5]triazine(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-dichloro-6-cyclohexyl-[1,3,5]triazine(17419-41-9)
• EPA Substance Registry System: 2,4-dichloro-6-cyclohexyl-[1,3,5]triazine(17419-41-9)

Safety Data

• Hazardous Substances Data: 17419-41-9(Hazardous Substances Data)

Upstream product

• 108-77-0 1,3,5-trichloro-2,4,6-triazine 
• 110-82-7 cyclohexane 
• 931-50-0 cyclohexylmagnesium bromide 
• 931-51-1 cyclohexylmagnesiumchloride 

Downstream Products

• 1091629-07-0 C₂₆H₅₁N₇O₂ 
• 1439923-18-8 1-[4-chloro-6-cyclohexyl-1,3,5-triazin-2-yl]-N-{[2-(trifluoromethyl)phenyl]methyl}-4-piperidinecarboxamide 
• 1439923-13-3 1-[4-(methylamino)-6-cyclohexyl-1,3,5-triazin-2-yl]-N-{[2-(trifluoromethyl)phenyl]methyl}-4-piperidinecarboxamide 
• 1091628-92-0 C₂₄H₄₅N₇O₂ 

Relevant articles and documents

New free-radical chain processes involving substitution of vinyl and aryl chlorides by alkanes, alkenes, esters and ethers

New free-radical substitutions of vinyl and aryl chlorides by alkanes, alkenes, ethers and esters are described. The free-radical chains are rationalized on the basis of the known kinetics of the elementary steps involved.

Combinatorial solid-phase synthesis of 4,6-diaryl and 4-aryl, 6-alkyl-1,3,5-triazines and their application to efficient biofuel production

Herein we report the solid-phase synthesis of a combinatorial aryl, alkyl-triazine library and its application to biofuel production. The combination of Grignard reactions and solid supported Suzuki coupling reactions afforded unique 120 triazine compounds with high purities and minimum purification steps. Through an unbiased phenotypic screening for improved biofuel generation in oleaginous yeast, we found one diaryl triazine derivative (E4) which increased the biolipid production up to 86%.

S-TRIAZINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME

Novel s-triazine compounds are disclosed and represented by the following: formula (Ia). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, where microbial infection is either a direct cause or a related condition.